$44.44
-2.06-4.43%
At close: -
$44.44
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Protagonist Therapeutics Stock Guidance | NASDAQ:PTGX | Benzinga
Protagonist Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Protagonist Therapeutics Inc (PTGX) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Protagonist Therapeutics (PTGX)?
There have been no specific sales or earnings guidance reported for Protagonist Therapeutics in recent months.
Browse guidance and forecast on all stocks.